RT Journal Article
SR Electronic
T1 801 Risk-benefit ratio in immunotherapy (IO) with or without chemotherapy (CT) according to PD-L1 expression: a model-based approach to inform treatment decisions in metastatic non-small cell lung cancer
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A899
OP A900
DO 10.1136/jitc-2023-SITC2023.0801
VO 11
IS Suppl 1
A1 Zhao, Molly
A1 Mangal, Naveen
A1 Zierhut, Matthew L
A1 Witjes, Han
A1 Chen, Ting
A1 Dang, Thao
A1 Ruiz, Ana
A1 Girish, Sandhya
A1 Kasichayanula, Sreeneeranj
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A899.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.